title: 2012 drug packaging review: many dangerous, reportable flaws.
abstract: Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002648:Child; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling; D004349:Drug Packaging / Q000592:standards* / Q000639:trends; D005260:Female; D006801:Humans; D010353:Patient Education as Topic; D010372:Pediatrics / Q000331:legislation & jurisprudence; D011041:Poisoning / Q000517:prevention & control; D011247:Pregnancy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal